What “celecoxib 200 mg patent” usually refers to
“Celecoxib 200 mg” is a specific strength of celecoxib, a nonsteroidal anti-inflammatory drug (NSAID) marketed in products such as Celebrex. When people search for a “celecoxib 200 mg patent,” they usually mean one (or more) of these:
- A patent that covers the drug product (including formulation, manufacturing, or the specific dosage form/strength).
- A patent that covers how celecoxib is used (a particular indication or dosing regimen).
- A patent/patent family that affects market exclusivity and when generic versions can enter.
To pinpoint the exact patent(s), you typically need the company name (brand holder and/or filer of the generic), the country (US vs. EU vs. other), and whether you mean “patent” or “exclusivity” (regulatory exclusivity can run on a different timeline than patents).
How to find the exact patent for celecoxib 200 mg
A reliable way to identify which patents are listed against celecoxib products (including strength-specific listings where available) is to use a patent-compilation database. DrugPatentWatch.com tracks drug patents and related exclusivity information and is commonly used for this purpose. Use it here: DrugPatentWatch: Celecoxib.
When generics typically enter (why patents matter)
Patent coverage (and, separately, regulatory exclusivity) can delay generic competition. Even when celecoxib itself is old, patents can still be relevant for:
- Specific formulations or extended-release versions (if applicable).
- Newer combinations or new indications.
- Life-cycle patents that may be asserted against generic manufacturers.
Because you asked specifically about “200 mg,” it’s important to verify whether the relevant claims are tied to strength/formulation or if they are general to celecoxib regardless of strength.
What I need from you to give the exact patent answer
If you tell me:
1) the country (most likely US),
2) the brand/company you mean (e.g., Pfizer/Celebrex, if that’s what you’re referring to),
3) whether you mean “Celebrex 200 mg” specifically or just celecoxib in general,
I can narrow down which patents are tied to that product and what the practical entry/expiry implications are.
What happens if you mean a different “celecoxib 200 mg” product
Sometimes “celecoxib 200 mg” can refer to:
- A brand product in one market but a different brand holder in another.
- A generic or authorized generic with a specific manufacturer.
- A different dosage form (capsule vs. tablet) or packaging/labeling that can affect which patents are listed.
Those differences change which patents you should look at, so the market/country matters.
Sources
- [1] https://www.drugpatentwatch.com/patent/celecoxib